Suppression of Growth and Dissemination in Human Pre-B Leukemia Cells by Trnnor Necrosis Factor-α in Scid Mice

References

• Sterling-Levis K., White L., Trickett A. E., Gramacho C., Pittman S.M., Tobias V. Heterotransplantation of early B-lineage acute lymphoblastic leukemia using a solubulized attachment matrix (matrigel). Cancer Res 1993; 53: 1222
   PubMed Web of Science ®Google Scholar
• Cavallo E, Riccardi C., Forni M., Pericle E, Bosco M. C., Giovarelli M., Soleti A., Forni G. Growth and dissemination of human malignant lymphoblasts in immunosuppressed nu/nu mice. Nat Immun Cell Growth Regul 1995; 10: 256
   Google Scholar
• Ishii E., Greaves A., Grunberger T., Freedman M.H., Letarte M. Tumor formation by a pre-B leukemia cell line in scid mice is associated with CD 10 induction and is promoted by Matrigel. Leukemia 1995; 9: 175
   PubMed Web of Science ®Google Scholar
• Shah S. A., Halloran P. M., Ferris C. A., Levine B. A., Bourret L. A., Goldmacher V S., Blattler W. A. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models. Cancer Res 1993; 53: 1360
   PubMed Web of Science ®Google Scholar
• Hardy B., Yampolski I., Kovjazin R., Galli M., Novogrodsky A. A monoclonal antibody against a human B lymphoblastoid cell line induces tumor regression in mice. Cancer Res 1994; 54: 5793
   PubMed Web of Science ®Google Scholar
• Durandy A., Brousse N., Rozenberg E, De Saint Basile G., Fischer A.M., Fischer A. Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies. J Clin Invest 1992; 90: 945
   PubMed Web of Science ®Google Scholar
• Schmidt-Wolf I. G.H., Nigrin R. S., Kiem H-P., Blume K.G., Weissman I. L. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J Exp Med 1991; 174: 139
   PubMed Web of Science ®Google Scholar
• Tritarelli E., Greco G., Testa U., Belardelli E, Peschle C., Proietti E. Combined interleukin-1β/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestoractive effect after cyclophosphamide-induced myelosuppression. Cancer Res 1994; 54: 6469
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Chelstrom L. M., Finnegan D., Tuel-Ahlgren L., Manivel C., Irvin J.D., Myers D. E. Effective immunochemotherapy of CALLA+Cμ+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD 19) pokeweed antiviral protein immunotoxin plus cyclophosphamide. Blood 1992; 79: 3116
   PubMed Web of Science ®Google Scholar
• Asher A., Mule J. J., Reichert C. M., Shiloni E., Rosenberg S. A. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. J Immunol 1987; 138: 963
   PubMed Web of Science ®Google Scholar
• Warzocha K., Robak T., Korycka A., Graczyk J., Pakulska W., Galazka G., Klysik J. The influence of recombinant human tumor necrosis factor-α alone and in combination with cyclophoshamide or methotrexate, on leukemia L1210 and normal hematopoieisis in mice. Archivum Immun et Ther 1991; 39: 587
   PubMedGoogle Scholar
• Murase T., Hotta T., Saito H., Ohno R. Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells. Blood 1987; 69: 467
   PubMed Web of Science ®Google Scholar
• Zhou M., Findley H. W., Ma L., Zaki S. R., Hill T., Hamid M., Hooper W.C., Ragab A. H. Effect of tumor necrosis factor-α on the proliferation of leukemic cells from children with B-cell precursor-acute lymphoblastic leukemica (BCP-ALL): studies of primary leukemic cells and BCP-ALL cell lines. Blood 1991; 77: 2002
   PubMed Web of Science ®Google Scholar
• Totpal K., Singh S., Lapushin R., Aggarwal B. B. Qualitative and quantitative differences in the cellular responses mediated through fas antigen and tumor necrosis factor receptor. J Interfer Cytokin Res 1996; 16: 259
   PubMed Web of Science ®Google Scholar
• Buck M., Sherwin S. A., Rosenblum M., Gutterman J. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 1987; 47: 2986
   PubMed Web of Science ®Google Scholar
• Hieber U., Heim M. E. Tumor necrosis factor for the treatment of malignancies. Oncology 1994; 51: 142
   PubMed Web of Science ®Google Scholar
• Rao P., Hsu K., Chao M. V. Upregulation of NF-kB-dependent gene expression mediated by the p75 tumor necrosis factor receptor. J Interfer Cytokin Res 1995; 15: 171
   PubMed Web of Science ®Google Scholar
• Higuchi M., Singh S., Chan H., Aggarwal B. B. Protease inhibitors differentially regulate tumor necrosis factor-induced apoptosis, nuclear factor-κB activation, cytotoxicity, and differentiations. Blood 1995; 86: 2248
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Manivel C., Arthur D., Chelstrom L. M., Finnegan D., Tuel-Ahlgren L., Irvin J. D., Myers D.E., Gunther R. In vivo efficacy of B43 (anti-CD 19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 1992; 79: 2201
   PubMed Web of Science ®Google Scholar
• Imai T., Koike K., Kubo T., Kikuchi T., Amano Y., Takagi M., Okumura N., Nakahata T. Interleukin-6 supports human megakaryocytic proliferation and differentiation in vitro. Blood 1991; 78: 1969
   PubMed Web of Science ®Google Scholar
• Nakahata T., Ogawa M. Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono-and multipotential hemopoietic progenitors. J Clin Invest 1982; 70: 1324
   PubMed Web of Science ®Google Scholar
• Fridman R., Giaccone G., Kanemoto T., Martin G. R., Gazdar A.F., Mulshine J. L. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small lung cancer cell lines. Proc Natl Acad Sci USA 1990; 87: 6698
   PubMed Web of Science ®Google Scholar
• Ishii E., Greaves A., Grunberger T., Freedman M.H., Letarte M. The induction of CD10 on a pre-B leukemia cell line occurs with progression of the disease in scid mice. Leukemia 1993; 7: 1592
   PubMed Web of Science ®Google Scholar
• Ishii E., Masuyama T., Yamaguchi H., Saito S., Irie K., Nomiyama A., Motoyoshi K., Miyazaki S. Production and expression of granulocyte and macrophage colony-stimulating factors in neonatal period: role of leukocytosis at birth. Acta Haematol 1995; 94: 23
   PubMed Web of Science ®Google Scholar
• Nakajima-Iijima S., Hamada H., Reddy P., Kakunaga T. Molecular structure of the human cytoplasmic beta-actin gene:interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 1985; 82: 6133
   PubMed Web of Science ®Google Scholar
• Pennica D., Nedwin G. E., Hayflick J. S., Seeburg P. H., Derynok R., Palladino M. A., Kohr W. J., Aggarwal B.B., Goeddel D. V. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984; 312: 724
   PubMed Web of Science ®Google Scholar
• Fuchs P., Strehl S., Dworzak M., Himmler A., Ambros P. F. Structure of the human TNF receptor 1 (p60) gene (TNFRF1) and localization to chromosome 12p13. Genomics 1992; 13: 219
   PubMed Web of Science ®Google Scholar
• Kohno T., Brewer M. T., Baker S. L., Schwartz P. E., King M. W., Hale K. K., Squires C. H., Thompson R.C., Vannice J. L. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 1990; 87: 8331
   PubMed Web of Science ®Google Scholar
• Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233
   PubMed Web of Science ®Google Scholar
• Cleary M. L., Smith S.D., Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 1986; 47: 19
   PubMed Web of Science ®Google Scholar
• Schmid R. M., Perkins N. D., Duckett C. S., Andrews P.C., Nabel G. J. Cloning of a NF-kappa B subunit which stimulates HIV transcription in synergy with p65. Nature 1991; 352: 733
   PubMed Web of Science ®Google Scholar
• Fridman R., Kibby M. C., Royce L. S., Zain M., Sweeney T. M., Jicha D. L., Yannelli J. R., Martin G.R., Kleinman H. K. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with matrigel. J Natl Cancer Inst 1991; 83: 769
   Google Scholar
• Kath R., Jambrosic J. A., Holland L., Rodeck U., Herlyn M. Development of invasive and growth factor-independent cell variants from primary melanomas. Cancer Res 1991; 51: 2205
   PubMed Web of Science ®Google Scholar
• Liesveld J. L., Winslow J. M., Frediani K. E., Ryan D.H., Abboud C. N. Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells. Blood 1993; 81: 112
   PubMed Web of Science ®Google Scholar
• Williams D. A., Rios M., Stephens C., Patel V. P. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature 1991; 352: 438
   PubMed Web of Science ®Google Scholar
• Miyake K., Weissman I. L., Greenberger J.S., Kincade P. W. Evidence of a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med 1991; 173: 599
   PubMed Web of Science ®Google Scholar
• Makrynikola V., Bradstock K. F. Adhesion of precursor-B acute lymphoblastic leukaemia cells to bone marrow stromal proteins. Leukemia 1993; 7: 86
   PubMed Web of Science ®Google Scholar
• Juliano R.L., Haskill S. Signal transduction from extracellular matrix. J Cell Biol 1993; 120: 577
   PubMed Web of Science ®Google Scholar
• Lowenberg B., Touw I. P. Hematopoietic growth factors and thier receptors in acute leukemia. Blood 1993; 81: 281
   PubMed Web of Science ®Google Scholar
• Carter A., Haddad N., Draxler I., Israeli E., Raz B., Rowe J. M. Expression and role in growth regulation of tumor necrosis factor receptors p55 and p75 in acute myeloblastic leukaemia cells. Br J Haematol 1996; 92: 116
   PubMed Web of Science ®Google Scholar
• Touw I., Groot-Loonen J., Broeders L., van Agthoven T, Hahlen K., Hagemeijer A., Lowenberg B. Recombinant hematopoietic growth factors fail to induce a proliferative response in precursor B acute lymphoblastic leukemia. Blood 1989; 73: 356
   Google Scholar
• Okabe M., Kunieda Y, Sugiwura T., Tanaka M., Miyagishima T, Saiki I., Minegawa T, Kurosawa M., Itaya T., Miyazaki T. Inhibitory effect of interleukin-4 on the in vitro growth of Phi-positive acute lymphoblastic leukemia cells. Blood 1991; 78: 1574
   PubMed Web of Science ®Google Scholar
• Thorn A. K., Alexander H. R., Andrich M. P., Barker W. C., Rosenberg S.A., Fraker D. L. Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan. J Clin Oncol 1995; 13: 264
   PubMed Web of Science ®Google Scholar
• Bigda J., Beletsky I., Brakebusch C., Varfolomeev Y, Engelmann H., Bigda J., Holtmann H., Wallach D. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J Exp Med 1994; 180: 445
   PubMed Web of Science ®Google Scholar
• Heller R. A., Song K., Fan N., Chang D. J. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 1992; 70: 47
   PubMed Web of Science ®Google Scholar
• Grell M., Douni E., Wajant H., Lohden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G., Pfizenmaier K., Scheurich P. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995; 83: 793
   PubMed Web of Science ®Google Scholar
• Tartaglia L. A., Ayres T. M., Wong G.H.W., Goeddel D. V. A novel domain within the 55kd TNF receptor signals cell death. Cell 1993; 74: 845
   PubMed Web of Science ®Google Scholar
• Watanabe-Fukunaga R., Brannan C. I., Copeland N. G., Jerkins N.A., Nagata S. Lymphoproliferation disorder in mice explained by the defects in Fas antigen that mediate apoptosis. Nature 1992; 356: 314
   PubMed Web of Science ®Google Scholar
• Nagafuji K., Shibuya T., Harada M., Mizuno S., Takenaka K., Miyamoto T, Okamura T., Gondo H., Niho Y. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 1995; 86: 883
   PubMed Web of Science ®Google Scholar